Tumor‐Targeted Glutamine Metabolism Blocker Synergizes with TiO 2 ‐Au Janus Nanoparticles for Enhanced Sono‐Metabolic Antitumor Therapy
Advanced Materials · 2025-03 · 37 (12)
DOI: 10.1002/adma.202418800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 14.02.2025. Verfasst von Jinling Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of nanomedicine and nanoformulations, CAS-HK Joint Lab for Biomaterials, CA…. Hauptthemen laut MEDLINE: Titanium, Gold, Glutamine, Antineoplastic Agents. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: China Scholarship Council, National Natural Science Foundation of China, Centre National de la Recherche Scientifique.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) is a promising therapeutic modality known for its non‐invasiveness, temporal‐spatial controllability, and deeper tissue penetration. However, the SDT treatment efficacy is still hampered by the scarcity of ideal sonosensitizers and complex tumor microenvironment (TME). To address these challenges, a sono‐metabolic nano‐composite (TiO 2 ‐Au@DON) using the metabolic reprogramming prodrugs of 6‐Diazo‐5‐oxo‐l‐norleucine (DON) grafted on TiO 2 ‐Au Janus nanoparticles (NPs) is fabricated. The coupling of TiO 2 and gold in the TiO 2 ‐Au@DON effectively prevents the fast recombination of excited electrons and holes under ultrasound irradiation. The result is the generation of higher levels of both type I and II reactive oxygen species (ROS) compared to pure TiO 2 , which helps overcome the limitations of SDT in the hypoxic TME. Furthermore, the TiO 2 ‐Au Janus NPs act as nano‐carriers, delivering DON prodrugs to the tumor site. The released DON can disrupt nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) and tumor redox homeostasis by reprogramming the metabolic pathways while it intensifies the activities of immune cells. This metabolic disruption amplifies SDT‐mediated oxidative stress, resulting in the increase of tumor sensitivity to ROS through TiO 2 ‐Au@DON‐integrated synergistic effects of SDT and glutamine reprogramming strategies. This increased sensitivity ultimately induces robust immunogenic cell death (ICD), enhancing antitumor therapeutic efficacy and remodeling the tumor's immunosuppressive microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of nanomedicine and nanoformulations, CAS-HK Joint Lab for Biomaterials, CAS Key Lab for Health Informatics, Institute of Biomedicine and Biotech…
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- University of Bordeaux, CNRS, LOMA, UMR 5798, Talence, F-33405, France.
- University of Bordeaux, CNRS, Bordeaux INP, ICMCB, UMR 5026, Pessac, F-33608, France.
- College of Integrated Circuits and Optoelectronic Chips (ICOC), Shenzhen Technology University (SZTU), 3002 Lantian Road, Pingshan District, Shenzhen, Guangdong, 518118, P. R. China.
ORCID-Profile: Marie Helene Delville
Förderung
- China Scholarship Council
- National Natural Science Foundation of China
- Centre National de la Recherche Scientifique
- Shenzhen Science and Technology Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Key Scientific Instrument and Equipment Development Projects of China
Zitieren
APA
Zheng, J., Zhao, F., Pariente, E., Xu, X., Zhang, X., Shabiti, S., Ke, Y., Hao, J., Delville, J. P., Delville, M. H., & Li, W. (2025). Tumor‐Targeted Glutamine Metabolism Blocker Synergizes with TiO 2 ‐Au Janus Nanoparticles for Enhanced Sono‐Metabolic Antitumor Therapy. Advanced Materials, 37(12). https://doi.org/10.1002/adma.202418800
Vancouver
Zheng J, Zhao F, Pariente E, Xu X, Zhang X, Shabiti S, et al. Tumor‐Targeted Glutamine Metabolism Blocker Synergizes with TiO 2 ‐Au Janus Nanoparticles for Enhanced Sono‐Metabolic Antitumor Therapy. Advanced Materials. 2025;37(12). doi:10.1002/adma.202418800
BibTeX
@article{Zheng2025,
author = {Zheng, Jinling and Zhao, Fenghuan and Pariente, Eugenie and Xu, Xiaoyu and Zhang, Xu and Shabiti, Shayibai and Ke, Yingying and Hao, Junjie and Delville, Jean-Pierre and Delville, Marie Helene and Li, Wenjun},
title = {Tumor‐Targeted Glutamine Metabolism Blocker Synergizes with TiO 2 ‐Au Janus Nanoparticles for Enhanced Sono‐Metabolic Antitumor Therapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {12},
doi = {10.1002/adma.202418800}
}
EUVIMED